Drug Development

To advance new drug candidates into clinical trials and the marketplace, a high-quality preclinical safety program that meets regulatory guidelines and is managed by a team you trust is of paramount importance. IITRI’s experienced study directors work collaboratively with you to design a customized preclinical drug development program that is tailored to the characteristics of your drug candidate and your timeline and follows regulatory guidelines. A high level of quality in preclinical study design and execution is ensured for your pipeline of drug candidates.